Cargando…
Genetically Engineered Lung Cancer Cells for Analyzing Epithelial–Mesenchymal Transition
Cell plasticity, defined as the ability to undergo phenotypical transformation in a reversible manner, is a physiological process that also exerts important roles in disease progression. Two forms of cellular plasticity are epithelial–mesenchymal transition (EMT) and its inverse process, mesenchymal...
Autores principales: | Kiełbus, Michał, Czapiński, Jakub, Kałafut, Joanna, Woś, Justyna, Stepulak, Andrzej, Rivero-Müller, Adolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953058/ https://www.ncbi.nlm.nih.gov/pubmed/31847480 http://dx.doi.org/10.3390/cells8121644 |
Ejemplares similares
-
How to Train a Cell–Cutting-Edge Molecular Tools
por: Czapiński, Jakub, et al.
Publicado: (2017) -
REPLACR-mutagenesis, a one-step method for site-directed mutagenesis by recombineering
por: Trehan, Ashutosh, et al.
Publicado: (2016) -
Comprehensive Review on Betulin as a Potent Anticancer Agent
por: Król, Sylwia Katarzyna, et al.
Publicado: (2015) -
Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties
por: Wawruszak, Anna, et al.
Publicado: (2019) -
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
por: Wawruszak, Anna, et al.
Publicado: (2019)